Burnett, JC and Ruthel, G and Stegmann, CM and Panchal, RG and Nguyen, TL and Hermone, AR and Stafford, RG and Lane, DJ and Kenny, TA and McGrath, CF and Wipf, P and Stahl, AM and Schmidt, JJ and Gussio, R and Brunger, AT and Bavari, S
(2007)
Inhibition of metalloprotease botulinum serotype A from a pseudo-peptide binding mode to a small molecule that is active in primary neurons.
Journal of Biological Chemistry, 282 (7).
5004 - 5014.
ISSN 0021-9258
Abstract
An efficient research strategy integrating empirically guided, structure-based modeling and chemoinformatics was used to discover potent small molecule inhibitors of the botulinum neurotoxin serotype A light chain. First, a modeled binding mode for inhibitor 2-mercapto-3-phenylpropionyl-RATKML (K i = 330 nM) was generated, and required the use of a molecular dynamic conformer of the enzyme displaying the reorientation of surface loops bordering the substrate binding cleft. These flexible loops are conformationally variable in x-ray crystal structures, and the model predicted that they were pivotal for providing complementary binding surfaces and solvent shielding for the pseudo-peptide. The docked conformation of 2-mercapto-3-phenylpropionyl- RATKML was then used to refine our pharmacophore for botulinum serotype A light chain inhibition. Data base search queries derived from the pharmacophore were employed to mine small molecule (non-peptidic) inhibitors from the National Cancer Institute's Open Repository. Four of the inhibitors possess Ki values ranging from 3.0 to 10.0 μM. Of these, NSC 240898 is a promising lead for therapeutic development, as it readily enters neurons, exhibits no neuronal toxicity, and elicits dose-dependent protection of synaptosomal-associated protein (of 25 kDa) in a primary culture of embryonic chicken neurons. Isothermal titration calorimetry showed that the interaction between NSC 240898 and the botulinum A light chain is largely entropy-driven, and occurs with a 1:1 stoichiometry and a dissociation constant of 4.6 μM.
Share
Citation/Export: |
|
Social Networking: |
|
Details
Item Type: |
Article
|
Status: |
Published |
Creators/Authors: |
Creators | Email | Pitt Username | ORCID |
---|
Burnett, JC | | | | Ruthel, G | | | | Stegmann, CM | | | | Panchal, RG | | | | Nguyen, TL | | | | Hermone, AR | | | | Stafford, RG | | | | Lane, DJ | | | | Kenny, TA | | | | McGrath, CF | | | | Wipf, P | pwipf@pitt.edu | PWIPF | | Stahl, AM | | | | Schmidt, JJ | | | | Gussio, R | | | | Brunger, AT | | | | Bavari, S | | | |
|
Date: |
16 February 2007 |
Date Type: |
Publication |
Journal or Publication Title: |
Journal of Biological Chemistry |
Volume: |
282 |
Number: |
7 |
Page Range: |
5004 - 5014 |
DOI or Unique Handle: |
10.1074/jbc.m608166200 |
Schools and Programs: |
Dietrich School of Arts and Sciences > Chemistry |
Refereed: |
Yes |
ISSN: |
0021-9258 |
MeSH Headings: |
Animals; Botulinum Toxins, Type A--chemistry; Botulinum Toxins, Type A--metabolism; Botulism--drug therapy; Botulism--enzymology; Cells, Cultured; Chick Embryo; Metalloproteases--chemistry; Metalloproteases--metabolism; Models, Molecular; Neurons--chemistry; Neurons--enzymology; Protease Inhibitors--chemistry; Protease Inhibitors--metabolism; Protease Inhibitors--therapeutic use |
PubMed ID: |
17092934 |
Date Deposited: |
09 Oct 2013 16:06 |
Last Modified: |
26 Sep 2022 16:29 |
URI: |
http://d-scholarship.pitt.edu/id/eprint/19856 |
Metrics
Monthly Views for the past 3 years
Plum Analytics
Altmetric.com
Actions (login required)
|
View Item |